Covid patients are more susceptible to secondary infection, says ICMR
May 28, 2021
Study says poor hospital practices, irrational antibiotics usage leading to higher mortality
Poor infection control practices in hospitals and irrational antibiotic prescription practices are triggering secondary infections in Covid-19 patients, leading to a higher mortality, according to a study coordinated by the Indian Council of Medical Research (ICMR).
The study, recently published in the journal
Infection and Drug Resistance, found that out of 17,534 Covid-19 patients admitted in 10 hospitals across the country, 3.6 per cent developed secondary bacterial or fungal infection while in the hospital. The mortality among patients who developed secondary infections was as high as 56.7 per cent compared to an overall mortality of 10.6 per cent among hospitalised Covid 19 patients in general, the study said.
Trigger warning: Mentions of casteist abuse and suicide
In April 2021, videos surfaced on the internet that showed Seema Singh, an associate professor at IIT Kharagpur, hurling abuses at students of marginalised castes and/or with physical disabilities during an online class. Her tirade was allegedly a response to a student not standing up for the national anthem and not saying “
Bharatmata ki jai“.
Another video shows Singh responding publicly to a student’s email asking for a few days’ leave after her grandfather had succumbed to COVID-19. In her response, Singh calls the request an example of “non-application of the human mind”, among other things.
All play, no work for the Prime Minister It has taken a brutal pandemic to expose the myth of Narendra Modi’s work ethic
Work is worship. The admirers of Narendra Modi believe that the prime minister is working hard to save India from the second wave of a virus that has brought the nation to its knees. However, given the reality on the ground, their devotion has acquired a touch of the absurd. Several members of the Union cabinet as well as leaders of the Bharatiya Janata Party recently shared a column attributed to the outfit’s media relations convener that assured India that Mr Modi, who, unlike his usual self, has been avoiding the limelight recently, has been hard at work. The evidence of the prime minister’s Calvinist spirit accompanied the piece, just in case Mr Modi’s critics the legion of anti-nationals according to BJP lore remain unconvinced. For instance, readers w
India Covid: Regulator nod for Phase 2, 3 clinical trials of Covaxin on 2-18-year-olds
Web Report/New Delhi
The trial involves two doses injected on days 0 and 28.
The Drugs Controller General of India (DCGI) on Thursday cleared Covaxin trials on those between two and 18 years, the first time such vaccines will be tested on children.
The DGCI accepted the recommendations of an expert committee on vaccines. The trial involves two doses injected on days 0 and 28 and will take place at the All India Institutes of Medical Science in Delhi and Patna and Meditrina Institute of Medical Sciences, Nagpur, among others.
Bharat Biotech along with the Indian Council of Medical Research and the National Institute of Virology is only Indian Covid shot maker. The company said its second and third phase trials will be done on 525 healthy volunteers.